# Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

> **NCT01186601** · PHASE1 · COMPLETED · sponsor: **Life Molecular Imaging SA** · enrollment: 30 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** PET tracer (BAY94-9392)

## Key facts

- **NCT ID:** NCT01186601
- **Lead sponsor:** Life Molecular Imaging SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186601, "Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01186601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*